Phoenix PharmaLabs

Phoenix PharmaLabs Phoenix PharmaLabs, Inc. is a privately held, pre-clinical-stage drug discovery company focusing on the development of new non-addicting opioids for pain.

is a privately held, pre-clinical-stage drug discovery company focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction. Phoenix’s product portfolio consists of early stage drug candidates with well-defined paths to clinical trials and regulatory approval. Phoenix PharmaLabs’ technology is based on the discov

ery of a family of ligands with simultaneous binding at all three opiate receptors: mu, kappa, and delta. These unique ligands, derived from opioid backbones using proprietary technology and manifesting balanced affinities and activities at all the opiate receptors, are the first ever pure opiate analgesics free of all significant dangerous opiate side-effects in pre-clinical studies

The company is currently advancing several analogs through pre-IND testing. (www.phoenixpharmalabs.com).

Address

999 W 1500 S
Woods Cross, UT
84087

Telephone

+13129431123

Website

Alerts

Be the first to know and let us send you an email when Phoenix PharmaLabs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Phoenix PharmaLabs:

Shortcuts

Share

Category